Mario Giovanni Chilelli

Author

Also Known As

M Chilelli, M G Chilelli, M. Chilelli, M.G. Chilelli, MARIO GIOVANNI CHILELLI, Mario Chilelli, Mario G. Chilelli, Mario Giovanni Chilelli

Publications

711

Citations

H-Index

Concepts

All Affiliations

Ospedale di Belcolle Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliera San Gerardo Istituto Cantonale di Patologia Agostino Gemelli University Polyclinic

About

Mario Giovanni Chilelli is an author at Ospedale di Belcolle specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	250
2	Health Sciences	1	1	79
3	Cell Biology	1	1	17
4	Head And Neck Surgery	1	1	79
5	Immunology	1	1	11

Mario Giovanni Chilelli

Publications

615

Citations

H-Index

Page 1

	Year	Citations
Five years survival in metastatic non‐small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial Paolo Lissoni, Mario Giovanni Chilelli, S. Villà, Journal of Pineal Research	2003	207
A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first‐line treatment of advanced non‐small cell lung cancer patients in a poor clinical state Paolo Lissoni, Franco Paolorossi, Antonio Ardizzoia, Journal of Pineal Research	1997	113
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, The Lancet Oncology Endocrine OncologyBreast OncologyMedicinePharmacologyEndocrine-sensitive Breast Cancer	2018	86
Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. F. Cognetti, Paola Pinnarò, Enzo Maria Ruggeri, Journal of Clinical Oncology World Health OrganizationSurgical OncologyNeoadjuvant TherapyCancer ManagementPathology	1989	79
A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients Paolo Lissoni, Franco Paolorossi, Gabriele Tancini, British Journal of Cancer OncologyMedicinePhase Ii StudyBreast CancerPharmacotherapy	1996	57
Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes Fabrizio Nelli, Luca Moscetti, Guido Natoli, International Journal of Clinical Oncology Metastatic Breast CancerBreast OncologyMedicinePathologyPredictive Value	2012	17
Bilateral Symptomatic Adrenal Myelolipoma Marialuisa Appetecchia, Mario Giovanni Chilelli, F. Sciarretta, Urologia Internationalis	1999	14
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis Carlo Signorelli, Mario Giovanni Chilelli, Isabella Sperduti, Anticancer Research	2019	11
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients Enzo Maria Ruggeri, Fabrizio Nelli, Diana Giannarelli, Scientific Reports ImmunohematologyIgg TiterImmunodeficienciesImmunologyImmunodominance	2022	11
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study Enzo Maria Ruggeri, Fabrizio Nelli, Agnese Fabbri, ESMO Open	2021	10

Page 1